Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide-Reference-Cited by-同舟云学术

Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

Published:2024-06 Issue:6 Volume:30 Page:588-596
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Mata Jonaphine Rae,Zahurak Marianna,Rosen Natalie^ORCID,DeZern Amy E.^ORCID,Jones Richard J.,Ambinder Alexander J.^ORCID

Funder

National Institutes of Health

NCI

Publisher

Elsevier BV

Reference36 articles.

1. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

2. Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation;Chen;Ther Adv Hematol,2020

3. Graft failure after allogeneic hematopoietic stem cell transplantation;Ozdemir;Transfus Apher Sci,2018

4. Graft failure in the modern era of allogeneic hematopoietic SCT;Olsson;Bone Marrow Transplant,2013

5. Risk factors for graft failure in allogeneic hematopoietic stem cell transplantation: a single-center study;Novitzky-Basso;Cell Ther Transplant,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxis;Bone Marrow Transplantation;2024-07-27

2. Post-Transplant Cyclophosphamide Attenuates the Adverse Effect of HLA Disparity and a Major ABO Mismatch on Graft Failure in Non-Myeloablative Allogeneic HCT;Transplantation and Cellular Therapy;2024-06